Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
8 shown of 9,337 total abstracts
  1. Abstract 67082026-04-05 · 21:30 CT · S406
    Quality of life outcomes with Keytruda in patients with RCC
    S. Antonia, M. Reck, C. Saura, et al. · Vall d'Hebron Institute of Oncology
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  2. Abstract 62442026-04-03 · 14:30 CT · Hall B1
    Real-world effectiveness of Opdivo vs standard of care in RCC
    S. Tolaney, R. Herbst, H. Borghaei, et al. · Johns Hopkins Kimmel Cancer Center
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  3. Abstract 66152026-04-04 · 20:00 CT · E450
    KEYNOTE-424: Keytruda (pembrolizumab) 1L in RCC
    M.C. Garassino, G. Curigliano, J. Brahmer · Chinese University of Hong Kong
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  4. Abstract 66632026-04-05 · 19:30 CT · E450
    Opdivo plus chemotherapy in previously untreated RCC: updated analysis from CheckMate-987
    M. Krop, C. Saura · Stanford Cancer Institute
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  5. Abstract 63892026-04-01 · 16:30 CT · E450
    Quality of life outcomes with Opdivo in patients with RCC
    H. Rugo, T. Mok, C. Saura, et al. · Institut Gustave Roussy
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  6. Abstract 65432026-04-05 · 21:00 CT · Hall B1
    Long-term follow-up of Keytruda 2L for RCC: KEYNOTE-327
    S. Tolaney, C. Saura, G. Curigliano · Massachusetts General Hospital
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  7. Abstract 63232026-04-02 · 18:00 CT · Arie Crown Theater
    Real-world effectiveness of Keytruda vs standard of care in RCC
    J. Brahmer, T. Mok, S. Modi · Mayo Clinic
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
  8. Abstract 64882026-04-01 · 18:00 CT · S100A
    Biomarker subgroup analysis of Opdivo in RCC (the CheckMate-228 study)
    R. Herbst, E. Winer, A. Spira · Institut Gustave Roussy
    Rapid Oral Abstract SessionGenitourinary Cancer—Kidney/Bladder📄🖼️🎬
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.